STIPULATION AND ORDER TO EXTEND BRIEFING DUE DATES

(First Request)

JAMES C. MAHAN, District Judge.

On October 5, 2017, Nevada Legislature ("Legislature") filed its Motion for Summary Judgement. (ECF no. 46). On October 26, 2017, plaintiffs Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization ("PhRMA and BIO") opposed the Legislature's Motion for Summary Judgment (ECF no. 65) and filed a Countermotion for Summary Judgment (ECF no. 66).

The parties wish to consolidate and to extend due dates for the Legislature's reply in support of its motion for summary judgment with its opposition to PhRMA and BIO's motion for summary judgment, and establish a single due date for that consolidated brief, which is limited to 30 pages, excluding exhibits, under LR 7-3(a). A similar extension for the due date for defendants Brian Sandoval and Richard Whitley ("State Defendants") to oppose PhRMA/BIO's motion for summary judgment will allow PhRMA and BIO to consider both oppositions before filing any reply and any consolidated reply will be limited to 30 pages, excluding exhibits.

NOW THEREFORE, IT IS HEREBY STIPULATED AND AGREED, by and among the parties, pursuant to LR IA 6-1, that the Legislature may file a consolidated brief, which is limited to 30 pages, excluding exhibits, under LR 7-3(a), as its reply in support of its motion for summary judgment and an opposition to PhRMA/BIO's countermotion for summary judgment on November 20, 2017, and that the State Defendants may file their opposition to PhRMA/BIO's motion for summary judgment on November 20, 2017. Any consolidated reply from PhRMA and BIO will be due on December 4, 2017 and will be limited to 30 pages, excluding exhibits.

IT IS FURTHER STIPULATED AND AGREED, that the parties execute this stipulation in good faith and not for the purposes of delay, and that they do not to waive any substantive or procedural right. The parties have not previously requested any extension of the due dates referenced herein.

IT IS SO ORDERED.